The filing is a routine notice of an upcoming earnings webcast. No actionable trading signal is present. Monitor the webcast on August 26-27 for the actual FY2026 financial results and any material updates on pipeline or commercial progress.
Price Chart
Executive Summary
Mesoblast filed a 6-K announcing a webcast to discuss operational highlights and financial results for the full year ended June 30, 2026. The filing is a routine notice of an upcoming earnings event and contains no actual financial data or material corporate developments. The webcast is scheduled for August 26-27, 2026.
Key Facts
- Mesoblast will host a webcast on August 26-27, 2026, to discuss FY2026 financial results and operational highlights.
- The filing is a notice of an upcoming event and contains no financial figures or material business updates.
- Ryoncil (remestemcel-L) is the first FDA-approved MSC therapy for SR-aGvHD in pediatric patients.
Financial Impact
No financial data provided in the filing.
Risk Factors
- No financial data or guidance was provided in this filing, limiting its immediate informational value.
- The filing does not disclose any material risks or changes to the company's outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001345099-26-000076 |
| Document: 0001345099-26-000076-index-headers.html | 0001345099-26-000076 |
| Document: 0001345099-26-000076-index.html | 0001345099-26-000076 |
| Document: 0001345099-26-000076.txt | 0001345099-26-000076 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | 20-F | $18.18 $15.48 | ▼ −14.85% | ▼ −14.34% | $14.07 (−22.58%) |
Aug 27, 2026 5w ago | Press Release | $18.18 $15.48 | ▼ −14.85% | ▼ −14.34% | $14.07 (−22.58%) |
Aug 24, 2026 5w ago | 6-K | $16.64 $15.92 | ▼ −4.33% | ▼ −5.64% | $14.07 (−15.41%) |
Aug 17, 2026 6w ago | Press Release | $17.02 $14.74 | ▼ −13.40% | ▼ −11.42% | $14.07 (−17.30%) |
Jul 30, 2026 9w ago | 6-K | $14.55 $18.18 | ▲ +24.95% | ▲ +20.98% | $14.07 (−3.26%) |
Jul 14, 2026 11w ago | 6-K | $16.74 $16.92 | ▲ +1.08% | ▼ −1.42% | $14.07 (−15.92%) |
Jul 14, 2026 11w ago | Press Release | $16.74 $16.92 | ▲ +1.08% | ▼ −1.42% | $14.07 (−15.92%) |
Jul 10, 2026 12w ago | 6-K | $15.44 $15.94 | ▲ +3.24% | ▲ +0.81% | $14.07 (−8.84%) |
Jul 10, 2026 12w ago | Press Release | $15.44 $15.94 | ▲ +3.24% | ▲ +0.81% | $14.07 (−8.84%) |
Jul 1, 2026 13w ago | 6-K | $14.09 $14.13 | ▲ +0.28% | ▲ +2.47% | $14.07 (−0.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access